Sunshine Biopharma Inc Net Asset Quality Index
Sunshine Biopharma Inc net asset quality index. Sunshine Biopharma Inc (SBFM) has a Net Asset Quality Index of 81.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $33.63 Million minus total liabilities of $6.09 Million yields net assets of $27.54 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Sunshine Biopharma Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sunshine Biopharma Inc (2007–2025)
Net asset quality index of Sunshine Biopharma Inc from 2007 to 2025. This chart shows how Sunshine Biopharma Inc's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 81.9%, representing net assets of $27.54 Million against total assets of $33.63 Million USD. Check Sunshine Biopharma Inc (SBFM) strategic asset index to assess the company's strategic physical and investment asset allocation.
Sunshine Biopharma Inc Net Asset Quality Index by Year (2007–2025)
Sunshine Biopharma Inc net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sunshine Biopharma Inc from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SBFM market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.6% | $23.04 Million | $30.08 Million | $7.04 Million | ▼ -0.3 pp |
| 2024 | 76.9% | $23.50 Million | $30.56 Million | $7.06 Million | ▼ -0.6 pp |
| 2023 | 77.5% | $21.21 Million | $27.35 Million | $6.14 Million | ▲ +4.3 pp |
| 2022 | 73.2% | $21.63 Million | $29.55 Million | $7.92 Million | ▲ +63.6 pp |
| 2021 | 9.6% | $211.66K | $2.20 Million | $1.99 Million | ▲ +100.9 pp |
| 2020 | -91.3% | $-954.84K | $1.05 Million | $2.00 Million | ▲ +658.0 pp |
| 2019 | -749.3% | $-735.38K | $98.14K | $833.53K | ▼ -744.4 pp |
| 2018 | -4.9% | $-55.75K | $1.15 Million | $1.20 Million | ▲ +217.8 pp |
| 2017 | -222.7% | $-573.36K | $257.49K | $830.85K | ▲ +102.9 pp |
| 2016 | -325.6% | $-209.70K | $64.40K | $274.10K | ▼ -236.9 pp |
| 2015 | -88.7% | $-597.04K | $673.26K | $1.27 Million | ▲ +181.6 pp |
| 2014 | -270.2% | $-387.58K | $143.42K | $531.00K | ▼ -245.6 pp |
| 2013 | -24.7% | $-7.71K | $31.24K | $38.95K | ▼ -76.9 pp |
| 2012 | 52.2% | $70.43K | $134.79K | $64.37K | ▼ -44.5 pp |
| 2011 | 96.8% | $103.00K | $106.44K | $3.43K | ▲ +2.3 pp |
| 2010 | 94.5% | $196.22K | $207.62K | $11.40K | ▲ +7.3 pp |
| 2009 | 87.2% | $97.80K | $112.12K | $14.31K | ▲ +439.4 pp |
| 2008 | -352.2% | $-17.71K | $5.03K | $22.74K | ▼ -442.1 pp |
| 2007 | 89.9% | $13.39K | $14.89K | $1.50K | — |